California 2025-2026 Regular Session

California Senate Bill SR103

Introduced
4/27/26  
Refer
4/27/26  

Caption

Relative to Tardive Dyskinesia Awareness Week.

Companion Bills

No companion bills found.

Previously Filed As

CA SCR68

Tardive Dyskinesia Awareness Week.

CA S1802

Tardive Dyskinesia Awareness Week

CA SR16

Designating first full week in May as Tardive Dyskinesia Awareness Week

CA SR0030

A resolution to designate May 4-10, 2025, as Tardive Dyskinesia Awareness Week.

CA SJR32

Designating the first full week in May as Tardive Dyskinesia Awareness Week.

CA AJR32

Designating the first full week in May as Tardive Dyskinesia Awareness Week.

CA SCR66

Designating The First Full Week Of May As "tardive Dyskinesia Awareness Week" In Delaware.

CA HR1295

Tardive Dyskinesia Awareness Week 2026; first full week in May; recognize

CA SR477

A resolution designating the first full week in May as "Tardive Dyskinesia Awareness Week".

CA HR0060

Recognizing the first full week of May 2025 as Tardive Dyskinesia Awareness Week.

Similar Bills

RI S0786

Prohibits prior authorization or a step therapy protocol for the prescription of a nonpreferred medication on their drug formulary used to assess or treat an enrollee's bipolar disorder, schizophrenia or schizotypal.

WI SB83

Utilization management controls for antipsychotic prescription drugs under the Medical Assistance program. (FE)

WI AB54

Utilization management controls for antipsychotic prescription drugs under the Medical Assistance program. (FE)

AZ SB1672

AHCCCS; antipsychotic drugs; authorization

MI HR0082

A resolution to declare May 5-9, 2025, as Tardive Dyskinesia Awareness Week in the state of Michigan.

NJ A2120

Requires NJ FamilyCare to reimburse inpatient providers for long-acting injectable antipsychotic drugs at outpatient reimbursement rate.

DE SCR66

Designating The First Full Week Of May As "tardive Dyskinesia Awareness Week" In Delaware.

MI SR0030

A resolution to designate May 4-10, 2025, as Tardive Dyskinesia Awareness Week.